Last reviewed · How we verify
Placebo pill + placebo patch
Placebo pill + placebo patch is a Small molecule drug developed by North Suffolk Mental Health Association. It is currently FDA-approved for Control/comparator in clinical trials for mental health conditions.
Placebo pill and patch produce therapeutic effects through patient expectation and the placebo effect rather than active pharmacological mechanisms.
A placebo pill and a placebo patch were used in clinical trials to study various conditions, including suicidal ideation, nicotine addiction, and eating disorders. The placebo patch is likely to be an inactive clear patch, as mentioned in ClinicalTrials.gov, while the placebo pill's composition is not specified.
At a glance
| Generic name | Placebo pill + placebo patch |
|---|---|
| Sponsor | North Suffolk Mental Health Association |
| Modality | Small molecule |
| Therapeutic area | Psychiatry/Mental Health |
| Phase | FDA-approved |
Mechanism of action
This product consists of inert formulations (pill and patch) designed to elicit a placebo response, where clinical benefit arises from patient belief and expectation rather than direct drug action. The combination of two delivery forms may enhance the perceived legitimacy of treatment. This approach is typically used in clinical research settings to serve as a control arm or to study the magnitude of placebo effects in psychiatric conditions.
Approved indications
- Control/comparator in clinical trials for mental health conditions
Common side effects
- Nocebo effects (adverse events attributed to placebo)
Key clinical trials
- Defining Neurobiological Links Between Substance Use and Mental Illness (NA)
- Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a Myelin Repair Therapy (PHASE1, PHASE2)
- Reward Sensitivity and Pharmacotherapy for Smoking Cessation (PHASE4)
- Cyclical Neuroactive Steroid Changes, Arousal, and Proximal Suicide Risk: An Experimental Approach (PHASE4)
- Treatment of Supine Hypertension in Autonomic Failure (CPAP) (NA)
- The Role of Estrogen in the Neurobiology of Eating Disorders (PHASE2)
- Atherosclerosis, Immune Mediated Inflammation and Hypoestrogenemia in Young Women (PHASE2)
- Vitamin D as a Nutritional Neoadjuvant During Photodynamic Therapy of Basal Cell Carcinoma (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo pill + placebo patch CI brief — competitive landscape report
- Placebo pill + placebo patch updates RSS · CI watch RSS
- North Suffolk Mental Health Association portfolio CI
Frequently asked questions about Placebo pill + placebo patch
What is Placebo pill + placebo patch?
How does Placebo pill + placebo patch work?
What is Placebo pill + placebo patch used for?
Who makes Placebo pill + placebo patch?
What development phase is Placebo pill + placebo patch in?
What are the side effects of Placebo pill + placebo patch?
Related
- Manufacturer: North Suffolk Mental Health Association — full pipeline
- Therapeutic area: All drugs in Psychiatry/Mental Health
- Indication: Drugs for Control/comparator in clinical trials for mental health conditions
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing